4372-15-0 Usage
General Description
Butan-2-ylpropanedioic acid, also known as diethylmalonic acid, is a compound with the chemical formula C9H16O4. It is an organic acid that is commonly used in organic synthesis and as a reagent in the production of pharmaceuticals and other organic compounds. The presence of a butyl group in the molecular structure of butan-2-ylpropanedioic acid makes it useful for its hydrophobic properties, which makes it suitable for use as a surfactant or emulsifier. Additionally, it is an important intermediate in the synthesis of various drugs and agrochemicals. Overall, butan-2-ylpropanedioic acid plays a significant role in the pharmaceutical and chemical industries due to its versatile properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 4372-15-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,7 and 2 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 4372-15:
(6*4)+(5*3)+(4*7)+(3*2)+(2*1)+(1*5)=80
80 % 10 = 0
So 4372-15-0 is a valid CAS Registry Number.
4372-15-0Relevant articles and documents
Mesoionic Xanthine Analogues: Phosphodiesterase Inhibitory and Hypotensive Activity
Glennon, Richard A.,Rogers, Michael E.,Smith, J. Doyle,El-Said, M. K.,Egle, John L.
, p. 658 - 661 (2007/10/02)
Several mesoionic thiazolopyrimidines and mesoionic 1,3,4-thiadiazolopyrimidines were evaluated as inhibitors of cyclic-AMP phosphodiesterase.While small alkyl substituents at the 6 position have no significant effect on activity, phenyl and benzyl substituents enhance activity.Mesoionic structures such as 1 (R2 = H; R8 = Et) possess 20 to 40 times activity of theophylline when the R6 substituent is phenyl or 4-chlorobenzyl.Methyl and ethyl substitution at the 2 position essentially abolishes activity.Although plagued by solubility problems, several of the mesoionic derivatives were found to display weak hypotensive effects in vivo.
